Cardiovascular disease and the renal transplant recipient

被引:46
作者
Kendrick, E [1 ]
机构
[1] Univ Calif Los Angeles, Med Ctr, Dept Nephrol, Los Angeles, CA 90095 USA
关键词
cardiovascular disease (CVD); kidney transplantation; hypertension; hyperlipidemia; homocysteine;
D O I
10.1053/ajkd.2001.28924
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular complications contribute to a significant proportion of the morbidity and mortality in renal transplant patients. Underlying disease states such as diabetes and hypertension as well as risk factors associated with chronic dialysis may cause many patients to have established coronary artery and peripheral vascular disease at the time of transplantation. Progression or new onset of disease can occur after transplantation due to the continued presence of risk factors for cardiovascular disease. The benefit of modification of these risk factors such as hypertension and hyperlipidemia has been well established in the general population and has more recently been explored in the renal transplant population, although long-term studies documenting an improvement in morbidity and mortality are not available. This article focuses on the potential benefit of modification of risk factors in this setting. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:S36 / S43
页数:8
相关论文
共 90 条
[1]   Hyperlipidaemia in renal transplant patients [J].
Aakhus, S ;
Dahl, K ;
Wideroe, TE .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (05) :407-415
[2]  
Abby S L, 1998, J Am Board Fam Pract, V11, P391
[3]  
ABTAHI P, 2001, GRAFT, V4, P266
[4]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[5]  
APANAY DC, 1994, TRANSPLANTATION, V58, P663
[6]   Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients [J].
Arnadottir, M ;
Hultberg, B ;
Vladov, V ;
NilssonEhle, P ;
Thysell, H .
TRANSPLANTATION, 1996, 61 (03) :509-512
[7]   Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[8]   Effects of Mediterranean diet on lipid levels and cardiovascular risk in renal transplant recipients [J].
Barbagallo, CM ;
Cefalù, AB ;
Gallo, S ;
Rizzo, M ;
Noto, D ;
Cavera, G ;
Camemi, AR ;
Marino, G ;
Caldarella, R ;
Notarbartelo, A ;
Averna, MR .
NEPHRON, 1999, 82 (03) :199-204
[9]  
Bostom AG, 2001, KIDNEY INT, V59, pS246, DOI 10.1046/j.1523-1755.2001.07855.x
[10]   Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors -: The role of metabolism -: Monograph for physicians [J].
Bottorff, M .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (15) :2273-2280